AKU’s Centre for Regenerative Medicine and Stem Cell Research (CRM) is to develop new, targeted therapies for a common form of blood cancer in adults, Philadelphia chromosome positive (Ph+) leukaemia. The aim is to understand the biology of the disease and use this knowledge to develop economically viable therapies. As Sujjawal Ahmad joins the team on this project having inspired from the scope and vision of the Centre, he conveys his admiration.
The Aga Khan University –University of California, San Francisco (UCSF) partnership began a comprehensive and integrated research programme at AKU in stem cell biology and regenerative medicine. Since then, the Centre, under the leadership of Professor Dr El-Nasir M A Lalani , is creating a strong regenerative medicine and stem cell research community across AKU campuses by inducting and training a cadre of clinical researchers, preparing them to undertake ambitious research programmes under the highest ethical, scientific, and medical standards for alleviating disease and improving human health in a state-of-the-art research facility.
Learn more about CRM:
Follow on Linkedin: